Alaunos Therapeutics Inc (TCRT)

$2.82 +0.11 (4.06%)
Market Cap 5.98M
Revenue (ttm) 10,000.00
Net Income (ttm) -4.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -46,800.00%
Debt to Equity Ratio 0.00
Volume 49,700
Avg Vol 655,056
Day's Range N/A - N/A
Shares Out 2.21M
Stochastic %K 29%
Beta -0.84
Analysts Strong Buy
Price Target $3.00

Company Profile

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos T...

Industry: Biotechnology
Sector: Healthcare
Phone: 346 355 4099
Address:
2617 Bissonnet Street, Suite 233, Houston, United States
LesleyMoore494
LesleyMoore494 Oct. 21 at 4:51 PM
$TCRT progressing in cancer therapy; AITX progressing in AI therapy for industries — clear proof of discipline and growth.
0 · Reply
shay7557
shay7557 Oct. 17 at 2:34 PM
$SGMO Sold the other half. Learned my lesson with $TCRT
1 · Reply
coldfacts
coldfacts Oct. 16 at 8:32 PM
$TCRT 👀
0 · Reply
Eliba
Eliba Oct. 16 at 3:52 PM
$TCRT Now it's a very cheap price compared to the near future, money on the floor 🔥⬆️
0 · Reply
Viktor1234
Viktor1234 Oct. 16 at 10:58 AM
$TCRT Can we expect another pump soon here?
0 · Reply
nerowinger
nerowinger Oct. 14 at 3:19 PM
$TCRT added
0 · Reply
MrWhiskIt
MrWhiskIt Oct. 11 at 3:01 PM
$ATCH $BAOS $CDT $TCRT We’re not either!!
0 · Reply
DajTrader
DajTrader Oct. 11 at 11:31 AM
$ATCH $BAOS $CDT $TCRT Struggling to make money? Were not!
0 · Reply
SqueezeRib
SqueezeRib Oct. 10 at 12:36 PM
$TCRT damn
0 · Reply
Ron_Burn
Ron_Burn Oct. 10 at 3:18 AM
$TCRT might buy if she hit $2 today
0 · Reply
Latest News on TCRT
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering

Jun 23, 2025, 8:00 AM EDT - 4 months ago

Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

May 14, 2025, 8:00 AM EDT - 5 months ago

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

ELAB

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Nov 14, 2023, 7:30 AM EST - 2 years ago

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS)

Aug 21, 2023, 7:32 AM EDT - 2 years ago

Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS)

ALLK BLFS KZR

Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives

Aug 14, 2023, 4:05 PM EDT - 2 years ago

Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives

Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies

Jun 29, 2023, 7:00 AM EDT - 2 years ago

Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies

Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting

May 25, 2023, 5:00 PM EDT - 2 years ago

Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting

Alaunos Therapeutics, Inc. (TCRT) Q1 2023 Earnings Call Transcript

May 10, 2023, 3:40 PM EDT - 2 years ago

Alaunos Therapeutics, Inc. (TCRT) Q1 2023 Earnings Call Transcript

Alaunos Therapeutics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:00 AM EDT - 2 years ago

Alaunos Therapeutics Reports First Quarter 2023 Financial Results

Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023

May 3, 2023, 8:30 AM EDT - 2 years ago

Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023

Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Apr 26, 2023, 12:30 PM EDT - 2 years ago

Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors

Mar 30, 2023, 7:00 AM EDT - 2 years ago

Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April

Mar 29, 2023, 5:30 PM EDT - 2 years ago

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April

Alaunos Therapeutics, Inc. (TCRT) Q4 2022 Earnings Call Transcript

Mar 7, 2023, 10:35 AM EST - 2 years ago

Alaunos Therapeutics, Inc. (TCRT) Q4 2022 Earnings Call Transcript

Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 7, 2023, 7:00 AM EST - 2 years ago

Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

Feb 28, 2023, 4:01 PM EST - 2 years ago

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023

Jan 9, 2023, 8:30 AM EST - 3 years ago

Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023

Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock

Nov 29, 2022, 9:01 AM EST - 3 years ago

Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock

Alaunos Therapeutics Announces Proposed Public Offering of Common Stock

Nov 28, 2022, 4:01 PM EST - 3 years ago

Alaunos Therapeutics Announces Proposed Public Offering of Common Stock

Alaunos Therapeutics Still Waiting For Home Run

Nov 21, 2022, 2:13 PM EST - 3 years ago

Alaunos Therapeutics Still Waiting For Home Run

Alaunos Therapeutics, Inc. (TCRT) Q3 2022 Earnings Call Transcript

Nov 14, 2022, 2:10 PM EST - 3 years ago

Alaunos Therapeutics, Inc. (TCRT) Q3 2022 Earnings Call Transcript

Alaunos Therapeutics Reports Third Quarter 2022 Financial Results

Nov 14, 2022, 7:00 AM EST - 3 years ago

Alaunos Therapeutics Reports Third Quarter 2022 Financial Results

Alaunos Therapeutics to Report Third Quarter 2022 Financial Results on November 14, 2022

Nov 8, 2022, 8:30 AM EST - 3 years ago

Alaunos Therapeutics to Report Third Quarter 2022 Financial Results on November 14, 2022

Alaunos Therapeutics to Present Data Highlighting its hunTR™ TCR Discovery Platform at the Society for Immunotherapy of Cancer 2022 Annual Meeting

Nov 7, 2022, 8:00 AM EST - 3 years ago

Alaunos Therapeutics to Present Data Highlighting its hunTR™ TCR Discovery Platform at the Society for Immunotherapy of Cancer 2022 Annual Meeting

Alaunos Therapeutics Highlights Data from TCR-T Library Phase 1/2 Trial at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference

Sep 21, 2022, 8:30 AM EDT - 3 years ago

Alaunos Therapeutics Highlights Data from TCR-T Library Phase 1/2 Trial at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference

Alaunos Therapeutics - T-Cell Therapies

Sep 14, 2022, 9:28 PM EDT - 3 years ago

Alaunos Therapeutics - T-Cell Therapies

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in September

Sep 7, 2022, 8:30 AM EDT - 3 years ago

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in September

Alaunos: Taking Autologous T-Cell Receptor Therapies To The Next Step

Aug 31, 2022, 4:00 PM EDT - 3 years ago

Alaunos: Taking Autologous T-Cell Receptor Therapies To The Next Step

Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference

Aug 24, 2022, 3:00 PM EDT - 3 years ago

Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference

Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q2 2022 Results - Earnings Call Transcript

Aug 15, 2022, 12:01 PM EDT - 3 years ago

Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q2 2022 Results - Earnings Call Transcript

Alaunos Therapeutics Reports Second Quarter 2022 Financial Results

Aug 15, 2022, 7:00 AM EDT - 3 years ago

Alaunos Therapeutics Reports Second Quarter 2022 Financial Results

Alaunos Therapeutics to Report Second Quarter 2022 Financial Results on August 15, 2022

Aug 8, 2022, 8:50 AM EDT - 3 years ago

Alaunos Therapeutics to Report Second Quarter 2022 Financial Results on August 15, 2022

Alaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations

Aug 4, 2022, 5:00 PM EDT - 3 years ago

Alaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations

CellChorus Announces Scientific Advisory Board

Jun 1, 2022, 11:39 AM EDT - 3 years ago

CellChorus Announces Scientific Advisory Board

Alaunos Therapeutics to Present at the Jefferies Healthcare Conference

Jun 1, 2022, 8:30 AM EDT - 3 years ago

Alaunos Therapeutics to Present at the Jefferies Healthcare Conference

Alaunos Therapeutics to Present Trials in Progress Poster for its TCR-T Library Phase 1/2 trial at the 2022 American Society of Clinical Oncology Annual Meeting

May 26, 2022, 5:01 PM EDT - 3 years ago

Alaunos Therapeutics to Present Trials in Progress Poster for its TCR-T Library Phase 1/2 trial at the 2022 American Society of Clinical Oncology Annual Meeting

Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q1 2022 Results - Earnings Call Transcript

May 16, 2022, 12:31 PM EDT - 3 years ago

Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q1 2022 Results - Earnings Call Transcript

Alaunos Therapeutics Reports First Quarter 2022 Financial Results

May 16, 2022, 7:30 AM EDT - 3 years ago

Alaunos Therapeutics Reports First Quarter 2022 Financial Results

Alaunos Therapeutics to Present at the H.C. Wainwright Global Investment Conference

May 10, 2022, 8:30 AM EDT - 3 years ago

Alaunos Therapeutics to Present at the H.C. Wainwright Global Investment Conference

Alaunos Therapeutics to Report First Quarter 2022 Financial Results on May 16, 2022

May 9, 2022, 8:30 AM EDT - 3 years ago

Alaunos Therapeutics to Report First Quarter 2022 Financial Results on May 16, 2022

Alaunos Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting

May 2, 2022, 4:31 PM EDT - 3 years ago

Alaunos Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting

Alaunos Therapeutics Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors

May 2, 2022, 8:30 AM EDT - 3 years ago

Alaunos Therapeutics Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors

Alaunos Therapeutics, Inc. (TCRT) Kevin Boyle on Q4 2021 Results - Earnings Call Transcript

Mar 30, 2022, 11:38 AM EDT - 3 years ago

Alaunos Therapeutics, Inc. (TCRT) Kevin Boyle on Q4 2021 Results - Earnings Call Transcript

Alaunos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

Mar 30, 2022, 7:30 AM EDT - 3 years ago

Alaunos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 30, 2022

Mar 16, 2022, 8:30 AM EDT - 3 years ago

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 30, 2022

Alaunos Therapeutics to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Mar 8, 2022, 4:05 PM EST - 3 years ago

Alaunos Therapeutics to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Ziopharm Rebrands As Alaunos Therapeutics

Jan 26, 2022, 11:19 AM EST - 4 years ago

Ziopharm Rebrands As Alaunos Therapeutics

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

Jan 26, 2022, 7:00 AM EST - 4 years ago

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

Ziopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual Meeting

Nov 9, 2021, 8:05 AM EST - 4 years ago

Ziopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual Meeting

ZIOPHARM Oncology, Inc. (ZIOP) CEO Kevin Boyle on Q3 2021 Results - Earnings Call Transcript

Nov 8, 2021, 7:45 PM EST - 4 years ago

ZIOPHARM Oncology, Inc. (ZIOP) CEO Kevin Boyle on Q3 2021 Results - Earnings Call Transcript

LesleyMoore494
LesleyMoore494 Oct. 21 at 4:51 PM
$TCRT progressing in cancer therapy; AITX progressing in AI therapy for industries — clear proof of discipline and growth.
0 · Reply
shay7557
shay7557 Oct. 17 at 2:34 PM
$SGMO Sold the other half. Learned my lesson with $TCRT
1 · Reply
coldfacts
coldfacts Oct. 16 at 8:32 PM
$TCRT 👀
0 · Reply
Eliba
Eliba Oct. 16 at 3:52 PM
$TCRT Now it's a very cheap price compared to the near future, money on the floor 🔥⬆️
0 · Reply
Viktor1234
Viktor1234 Oct. 16 at 10:58 AM
$TCRT Can we expect another pump soon here?
0 · Reply
nerowinger
nerowinger Oct. 14 at 3:19 PM
$TCRT added
0 · Reply
MrWhiskIt
MrWhiskIt Oct. 11 at 3:01 PM
$ATCH $BAOS $CDT $TCRT We’re not either!!
0 · Reply
DajTrader
DajTrader Oct. 11 at 11:31 AM
$ATCH $BAOS $CDT $TCRT Struggling to make money? Were not!
0 · Reply
SqueezeRib
SqueezeRib Oct. 10 at 12:36 PM
$TCRT damn
0 · Reply
Ron_Burn
Ron_Burn Oct. 10 at 3:18 AM
$TCRT might buy if she hit $2 today
0 · Reply
StockScanners
StockScanners Oct. 10 at 2:30 AM
$TCRT reached 8.11, dam son lets go team, be ready for next idea
0 · Reply
Viktor1234
Viktor1234 Oct. 9 at 10:23 PM
$TCRT What happened to this? Should have been careful.
0 · Reply
waitfordump
waitfordump Oct. 9 at 9:04 PM
$TCRT what a garbage stock from 8 to 3.70
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 8:09 PM
Keep a close watch on CMCT! $SIDU $UBER $TCRT $ALAB ll
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 7:30 PM
Keep a close watch on CMCT! $VZ $TCRT $UBER $SNDK k
0 · Reply
Tazdoc88
Tazdoc88 Oct. 9 at 6:50 PM
$TCRT
0 · Reply
SqueezeRib
SqueezeRib Oct. 9 at 6:48 PM
$TCRT Again!
0 · Reply
PaulLaurent
PaulLaurent Oct. 9 at 6:45 PM
📢📊 Unusual Volume Stocks 📊📢 $JFU $AMBO $TCRT $BDRX $ATHE
0 · Reply
chinchinbull
chinchinbull Oct. 9 at 5:16 PM
Afternoon movers $CETY VS $NUAI VS $BAOS vs $TCRT
0 · Reply
KiaShipman1066
KiaShipman1066 Oct. 9 at 5:05 PM
$TCRT may be innovative in biotech, but AITX is innovating across entire industries — construction, banking, logistics, healthcare — real enterprise contracts, not concepts.
0 · Reply
Tazdoc88
Tazdoc88 Oct. 9 at 3:51 PM
$TCRT
1 · Reply
BreakoutBullz
BreakoutBullz Oct. 9 at 3:24 PM
Excellent plays for the community!💰 Link in bio! $BAOS ran 🔥💰🎯 +66% from 5.00 call! $BJDX ran 🔥💰🎯 +45% from 3.80 call! $TCRT ran 🔥💰🎯 +35% from 6.00 call! $EPWK ran 🔥💰🎯 +28% from .12 call! $ATCH ran 🔥💰🎯 +23% from .50 call! We posted on ST earlier!📋
0 · Reply